Adtran brings energy-efficient multigigabit broadband to homes and businesses with next-gen ONTs
4.5.2023 15:00:00 EEST | Business Wire | Press release
Adtran today launched its SDX 630 Series, a new generation of 10G symmetric XGS-PON optical network terminals (ONTs) designed to address the demands of residential and business customers in the multigigabit era. The flexible, open technology provides a cost-effective path to high-bandwidth services while enabling service providers to support existing FTTH subscribers. With speeds up to 10Gbit/s, the SDX 630 Series meets all connectivity needs, from streaming high-quality videos on multiple devices to running data-intensive cloud applications. The low-power devices are easy to deploy and feature zero-touch service provisioning capabilities. Coupled with Adtran service delivery gateways (SDGs), they meet the demand of current and future Wi-Fi standards and enable seamless integration with Adtran’s intelligent Mosaic One management system for enhanced control and monitoring.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230504005600/en/
Adtran’s SDX 630 Series will be key in helping service providers deliver multigigabit broadband in the most sustainable and cost-effective way. (Photo: Business Wire)
“In today’s digital age, households and enterprises require high-capacity broadband with unparalleled quality to stay connected and productive. That’s why we’ve engineered our new generation of XGS-PON ONTs to simultaneously meet all the needs of remote work, gamers and cloud-based applications. Our SDX 630 Series enables service providers to succeed in the multigigabit era by harnessing the benefits of high-speed fiber optic transmission and the flexibility offered by our full portfolio of customer premises equipment,” said Robert Conger, SVP of technology and strategy at Adtran. “Our ONTs are specifically designed to remain at the premises for the long term, meeting the requirements of ever-advancing Wi-Fi residential gateways for years to come. Maintenance-free and with a compact, modern design, they discretely blend into a range of environments.”
The SDX 630 Series of ONTs addresses today’s key challenges around delivering cost-efficient, converged residential and business services. Part of the Adtran ecosystem of open-API access products, they enable easy integration into existing network infrastructure and SDN-based management systems. Simple zero-touch provisioning allows for end user installations without the need for truck rolls, reducing complexity and opex. What’s more, they feature advanced operational monitoring features, such as Y.1731, continuity check and ONT-generated multigigabit speed tests. With 10GbE and 2.5GbE LAN interfaces, integrated voice ports, as well as outdoor ONT variants, service providers can offer any flavor of multigigabit service. Also available is an XGS-PON SFP+ ONT that offers a complete ONT in a small form factor pluggable package.
“Meeting today’s soaring bandwidth demands takes more than just great technology. It takes a company that’s committed to building environmentally responsible solutions. Our SDX 630 Series is a distillation of everything we’ve learned over the past decade. It features recyclable enclosures, cloud-hosted documentation and optimized packaging, all designed to put sustainability first,” commented Eric Presworsky, GM of residential solutions at Adtran. “We’ve worked closely with service providers to address some of their key concerns when it comes to building networks in a cost-effective and sustainable way. For example, just take a look at the low-power capabilities of our SDX 630 Series. It’s compliant with Energy Efficient Ethernet (EEE) and European Union COC v8. We’re confident that it’s going to help service providers in a big way.”
Further information on the SDX 630 Series is available in these slides.
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of ADVA. Find more at Adtran, LinkedIn and Twitter.
Published by
ADTRAN Holdings, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230504005600/en/
Contact information
For media
Gareth Spence
t +44 1904 699 358
public-relations@adva.com
For investors
Steven Williams
+49 89 890 665 918
investor@adtran.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
